The first technical resistance point for Goldcorp Inc. (NYSE:GG) will likely come at $10.97, marking a 1% premium to the current level. The second resistance point is at $11.09, about 2.07% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $10.7, the lower end of the range. GG’s 14-day MACD is 0.01 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 58.26, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 18.54 percent, which is low when compared to that of the 50-day’s 31.11 percent.
Goldcorp Inc. (GG) trade volume has increased by 6.56% as around 11,664,142 shares were sold when compared with its 50-day average volume of traded shares which is 10,946,448. At the moment, GG is witnessing a uptrend, as it is trading 1% above its 20-day SMA, 8.29% above its 50-day SMA, and -4.55% above its 200-day SMA. The company runs an ROE of roughly 0.5%, with financial analysts predicting that their earnings per share growth will be around 3.57% per annum for the next five year. This will be compared to the -17.9% decrease witnessed over the past five years.
The last few days have been rough for Goldcorp Inc. (NYSE:GG), as its price has decreased by -2.69% during the week. It has also performed better over the past three months, as it added around 15.78% while it has so far retreated around -11.99% during the course of a year. The price of the stock went down by -$0.11 now trading at $10.86. Their shares witnessed a 28.98% increase from the 52-week low price of $8.42 they recorded on 2018-10-25. Even though it is still -34.99% behind the $14.66 high touched on 2018-04-18. The stock of GG recorded 10.82% uptrend from the beginning of this year till date. The 12-month potential price target for Goldcorp Inc. is set at $13.16. This target means that the stock has an upside potential to increase by 21.18% from the current trading price.
When giving their opinion, around 61.11% of Wall Street analysts, which represents 11 out of 18 rated the stock as a Buy. 6 brokerage firms of the remaining 33.33% rated the stock as a Hold with 1 analyst rating it as a sell. Overall, the number of aggregate GG shares held by institutional investors represents 68.8% of total shares. 39 institutions entered new Goldcorp Inc. (NYSE:GG) positions, 166 added to their existing positions in these shares, 170 lowered their positions, and 49 exited their positions entirely.
The shares of Novavax, Inc. (NASDAQ:NVAX) has decreased by -0.45%, and now trading at $2.19 on the Wall Street in the intra-day deal, with their shares traded now around 8,516,285. This is a decline of -1,170,829 shares over the average 9,687,114 shares that were traded daily over the last three months. The stock that is trading at $2.19 went higher by 90.43% from its 52-week low of $1.15 that it attained back on 2018-08-06. The stock recorded a 52-week high of $2.75 nearly 349 days ago on 2018-03-01.
NVAX stock hasn’t performed well over the past 30 days, as it lost -0.45% while its price climbed by 19.02% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -4.37% over the last week. The stock’s 12-month potential target price is now at $4.38. This means that the stock price might likely increase by 100% from its current trading price.7 out of 9 Wall Street analysts which represents 77.78% rated the stock as a buy while the remaining 22.22 rated it as a hold, with 0 of analysts rating it as a sell.
Novavax, Inc. (NASDAQ:NVAX) has been utilizing an ROE that is roughly 179.3%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the -23.7% drop that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 0.37% above its 20-day SMA, 2.56% above its 50-day SMA, and 26.67% above its 200-day SMA. In percentage terms, the aggregate Novavax, Inc. shares held by institutional investors is 42.1%. 21 institutions jumped in to acquire Novavax, Inc. (NVAX) fresh stake, 66 added to their current holdings in these shares, 62 lowered their positions, and 18 left no stake in the company.
The stock’s 9-day MACD is -0.05 and this negative figure indicates a downward trading trend. The company’s 9-day RSI score is 46.54, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 37.61 percent, which is less when compared to that of the 50-day’s 73.56 percent. On the daily chart, we see that the stock could reach the first level of resistance at $2.23, sporting a 1.79% premium to the current level. The next resistance point is at $2.27, representing nearly 3.52% premium to the current market price of Novavax, Inc. (NVAX). On the other hand, failure to breach the immediate hurdles can drag it down to $2.13, the lower end of the range.